Showing results (1431-1440 of 1,520) with videos related to
Sort By:
Pageof 152
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2020
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal AdenocarcinomaChangqing Xie, Austin G Duffy, Gagandeep Brar, et al.The Lancet. Oncology|January 21, 2014
Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trialArun Rajan, Corey A Carter, Arlene Berman, et al.The Oncologist|March 11, 2022
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal CancerJason M Redman, Yo-Ting Tsai, Benjamin A Weinberg, et al.Blood|March 1, 2011
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaRichard L Piekarz, Robin Frye, H Miles Prince, et al.Proceedings of the National Academy of Sciences of the United States of America|June 27, 2003
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomaGiao Q Phan, James C Yang, Richard M Sherry, et al.The Oncologist|February 8, 2021
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple MyelomaDickran Kazandjian, Alexander Dew, Elizabeth Hill, et al.JAMA Oncology|February 20, 2025
Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical TrialCharalampos S Floudas, Meghali Goswami, Renee N Donahue, et al.Journal of Nutrition Education and Behavior|December 3, 2014
The Shaping Healthy Choices Program: design and implementation methodologies for a multicomponent, school-based nutrition education interventionRachel E Scherr, Jessica D Linnell, Martin H Smith, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2017
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular CarcinomaAustin G Duffy, Chi Ma, Susanna V Ulahannan, et al.Oncoimmunology|September 14, 2016
TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancerLauren V Wood, Antonio Fojo, Brenda D Roberson, et al.Pageof 152